L. López Gómez

发表

P. Roldán, J. L. Barcia Salorio, G. Hernandez, 1985, Applied neurophysiology.

Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma. The ONCOPAZ Cooperative Group.

J. Feliu, M. González Barón, J. Dorta, 2000, Cancer.

Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma

J. Feliu, J. Castro, M. González Barón, 2000 .

Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.

M. Martín, F. Rivera, R. Pazo-Cid, 2017, European journal of cancer.

Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin

E. Espinosa, J. Feliu, M. Barón, 1999, Cancer.

Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas.

E. Espinosa, J. Feliu, J. Castro, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Mediastinal extravasation of doxorubicin

L. López Gómez, J. A. Andrade Santiago, T. Quintanar Verdúguez, 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

M. Martín, F. Rivera, R. Pazo-Cid, 2017, European journal of cancer.